Mikio Kajihara

1.5k citations
49 papers · 908 indexed · h-index 19
Topics
Immunotherapy and Immune Responses (13 papers)Cancer Immunotherapy and Biomarkers (9 papers)Liver Disease Diagnosis and Treatment (7 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Mikio Kajihara

48 papers receiving 886 citations

Peers

Mikio Kajihara
Comparison fields: 5 of 84
  • Molecular Biology 275
  • Oncology 263
  • Immunology 233
  • Epidemiology 186
  • Hematology 167
Replace Tomohiro Kurokawa with:
Tomohiro Kurokawa Japan
Federico Moriconi Germany
Toshiyuki Bohgaki Japan
Michel Guiguet France
G. H. Millward‐Sadler United Kingdom
Christoffer Soendergaard Denmark
Tania Silvestri Italy
Fabrizio Scatena Italy
Adriana Delwail France
Shiva Kumar Shanmukhappa United States
Mikio Kajihara relative to Tomohiro Kurokawa Japan Tomohiro Kurokawa's profile →
Citations per field
00.5×3.3×
Tomohiro Kurokawa · 1×
Citations per year

Countries citing papers authored by Mikio Kajihara

Since Specialization
Citations

This map shows the geographic impact of Mikio Kajihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Kajihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Kajihara more than expected).

Fields of papers citing papers by Mikio Kajihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikio Kajihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Kajihara. The network helps show where Mikio Kajihara may publish in the future.

Co-authorship network of co-authors of Mikio Kajihara

This figure shows the co-authorship network connecting the top 25 collaborators of Mikio Kajihara. A scholar is included among the top collaborators of Mikio Kajihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikio Kajihara. Mikio Kajihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 42
2 26
3 13
4 5
5 24
6 8
7 2
8 11
9 40
10 6
11 2
12 1
13 6
14 53
15 44
16 9
17 18
18 82
19 58
20 6

About Mikio Kajihara

Mikio Kajihara is a scholar working on Hepatology, Immunology and Oncology, having authored 49 papers that have together received 908 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (137 citations), Hematology (167 citations) and Immunology (233 citations). Mikio Kajihara has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Kazuki Takakura, Shigeo Koido, Masataka Kuwana, Yuka Okazaki, Shinzo Kato, Hiromasa Ishii, Toshifumi Ohkusa, Yutaka Kawakami, Yasuo Ikeda and Zensho Ito. Their work appears in journals such as Gastroenterology, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026